Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by bringon10baggeron Jun 22, 2020 7:28pm
128 Views
Post# 31178767

RE:Interesting Facts

RE:Interesting FactsLooks as though reading is not a strong point of yours, clearly states in prospectus of how phase 3 is being funded.......why do you remain here looting your bs when you say you  dumped all your shares.........quote=AlbertaGuy9]Out of 25 million Financing ---Only 5 million may be used for Phase 3. Wow what about rest of 20 millions? May be spent to save CEO marriage and or feed the experimental rats? what about phase 3? LOL

Dumbos - Check the SEDAR- they want atleast 100s of millions to start Phase 3. Smart shorters relaized this. They increased their short positions since last week. Check the Short report. Take any pump or bash posted on this board with grain of salt. Do your own DD. You will soon realize that this is PUMP and DUMP by Insiders and Echelon.

Selective Asset Management Analyst Pumper - Robert Mcwhirter sold his entire position - now running away from this stock.



[/quote]

Bullboard Posts